PharmaVOICE Podcasts

Why a Retail Strategy is Critical to your Brand Success

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 27 Feb 2014 09:23:00 -0600

In this episode, Mr. Domann discusses a retail strategy for minimizing prescription abandonment for brands at many stages in the product lifecycle. We cover how pharmacies and pharmacists play integral roles in the strategy.

Thought Leader: Dick Domann, Vice President, Pharmacy Services, TrialCard Inc.

Play podcast

Who are the Uninsured in America?

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 18 Feb 2014 08:19:00 -0600

In this episode, Patricia Ensor discusses the characteristics and behaviors of the uninsured, how they relate to the Affordable Care Act (ACA), and what it means for Pharma.

Thought Leader: Patricia Ensor, RPh, Senior Advisor, Kantar Health

Play podcast

Biobetters: Challenges and Opportunities

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 30 Dec 2013 09:27:00 -0600

The market of biologics is growing at a nearly twice the rate of pharma as a whole. Biobetters are the next big opportunity for biopharma to benefit from this growth. This podcast will explore the regulatory and scientific considerations for the development of biobetters.

Thought Leader: Hazel Gorham, Ph.D., Director, Biosimilars Development, PRA

Play podcast

How Working Together Effectively on a Clinical Trial is Like Doing a Successful Skydive

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 30 Dec 2013 09:15:00 -0600

In this episode, Ms. Ruby discusses how clinical trials are like skydiving, what some of the key challenges are in clinical trials, solving unexpected challenges, and creating a productive and collaborative relationship between CROs and sponsors.

Thought Leader: Barbara Ruby, Project Director, SynteractHCR, Inc.

Play podcast

Risk-based monitoring (RBM): A shift in paradigm from the traditional experimental design

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 30 Dec 2013 07:13:00 -0600

In this episode, Mr. Penniston and Ms. Taber talk about risk-based monitoring what it is, why it's important, what are the components, what skill sets or tools are necessary, and the challenges and opportunities related to risk-based monitoring.

Thought Leaders: Mark Penniston, Senior Vice President and General Manager, Clinical Analytics, Theorem Clinical Research and Alison Taber, Vice President of Global Data Management, Theorem Clinical Research

Play podcast

Creating Great Multichannel CRM Experiences: Advice from a 28-year Pharma Expert

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 14 Nov 2013 09:19:00 -0600

In this episode, Mr. Lammers talks about using a multichannel business strategy in life science companies. He defines the multichannel approach, covers the core challenges, offers his review on Pharma's adoption of multichannel, and provides advice for commercial leaders.

Thought Leader: Peter Lammers, VP, Strategy, Veeva Systems

Play podcast

Building Better Medication Adherence Models to Improve Health Outcomes

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 14 Nov 2013 08:08:00 -0600

In this episode, Mr. Dockery covers several issues related to patient adherence, including using Big Data to predict patient behavior and improve adherence in a patient population, as well as how to accurately measure adherence rates.

Thought Leader: Jim Dockery, Executive Director, Market Data Insights and Innovation, Adheris

Play podcast

Unlocking the Power of Strategic Workforce Planning

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 13 Nov 2013 09:06:00 -0600

In this episode, we discuss the challenges in pharma regarding workforce management, the growing trend of strategic workforce planning, and how this phenomenon will continue to evolve over the next 5 years.

Thought Leader: Mark Lanfear, Global Practice Leader, Americas Scientific Product Group, Kelly Services, Inc.

Play podcast

Change Agents + Team Coaching = Transformation from the Inside Out at Sanofi

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 30 Sep 2013 09:17:00 -0500

In this episode, Craig Flanagan and DJ Mitsch talk about a major culture change at Sanofi Pharmaceuticals North America: how they designed it, implemented it, what the results were, and the future of this significant undertaking. This podcast will be of great interest to anyone at a large company who is considering or has decided to implement a powerful culture change.

Thought Leaders: Darelyn "DJ" Mitsch, President, The Pyramid Resource Group, Inc. and Craig Flanagan, VP, Business Excellence and Commercial Capabilities, sanofi-aventis

Play podcast

Risk-Based Monitoring for Late Phase: Implementation Strategies

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 28 Aug 2013 09:02:00 -0500

In this episode, Ms. Harrison discusses the past, present, and future of Risk-based Monitoring. She also covers challenges and solutions, as well as a real-life example of RBM in a clinical study.

Thought Leader: Maria Harrison, Vice President, Late Phase Services, PRA

Play podcast

Disruptive Innovation in R&D Processes

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 31 May 2013 11:20:00 -0500

In this episode, Dr. Davis discusses open innovation, nontraditional partnerships, collaboration, new technologies, and the future of R&D.

Thought Leader: Dr. Hugh Davis, VP and head of Biologics Clinical Pharmacology Biotechnology Center of Excellence, Janssen Research and Development

Play podcast

Immersive Learning: What You Need to Know to Build Faster, Smarter Commercial Teams

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 30 May 2013 08:57:00 -0500

In this episode, Mr. O'Grady speaks about immersive learning, what it is, and how it is the best choice for many types of mission-critical training.

Thought Leader: Garry O'Grady, SVP and General Manager, Pharmaceutical Institute

Play podcast

Developing Robust Potency Assays for Validation

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 30 Apr 2013 11:38:00 -0500

In this episode, Peter Wunderli, Ph.D., discusses PPD's recent laboratory facility expansion, outlines challenges and critical factors in cell-based bio bioassay product development, talks about disease states suitable for this type of technology, and finally, takes a look into the future of cell-based assays.

Thought Leader: Peter Wunderli, Ph.D., Associate Director, Biopharmaceutical Services at PPD

Play Podcast

What is Creativity?

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 30 Apr 2013 08:56:00 -0500

In this episode, Anthony Rotolo talks about creativity in the health and wellness space. We cover the importance of creativity in advertising, how to be creative, and, when used properly, how creativity influences behavior change.

Thought Leader: Anthony Rotolo, Chief Creative Officer, TRUE Health + Wellness

Play podcast

Value of a Credential in the Medical Publications Profession

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 22 Apr 2013 10:34:00 -0500

In this episode, Stacy Simpson Logan talks about the value of obtaining a CMPP credential for employees and employers as well as the future of the CMPP program. CMPP stands for Certified Medical Publication Professional and is administered by ISMPP, the International Society for Medication Publication Professionals.

Thought Leader: Stacy Simpson Logan, Chair, CMPP Board of Trustees President, Waterfall Consulting

Play podcast

What Do Mick Jagger, Diabetes, Heart Disease, and Cancer Have in Common?

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 29 Mar 2013 08:32:00 -0500

In this episode, Ms. Hammond talks about our aging society and how the industry needs to address its therapies to reflect the differences in age groups, including the old, and the very old.

Date Posted: 03/28/2013 Size: 9.6MB Length: 00:20:52

Thought Leader: Melissa Hammond MSN, GNP, Managing Director, Snowfish

Play podcast

Transitioning Clinical Trial Patients to Commercial Supply via Managed Access Programs

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 29 Mar 2013 08:28:00 -0500

This podcast describes how Managed Access Programs can continue treatment access for patients coming out of registration or other clinical trials who need to transition to commercial supply.

Thought Leaders: Suzanne Gagnon, MD, Chief Medical Officer, Idis, Karen Searle PhD, Study Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development and Michelle Gee, PhD, Director, Neuroscience & General Medicine (NGM), Eisai Global Clinical Development

Play podcast

Conducting User Testing to Improve Clinical Trial Technologies

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 31 Jan 2013 12:59:00 -0600

Thought Leader: Joseph Bedford, Ph.D., Director of Marketing, Almac Clinical Technologies

In this episode, we discuss how user testing research improves the clinical trial process for patients, sites, and sponsors.

For more information about Almac Clinical Technologies, visit www.almacgroup.com.

Play Podcast.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Demystifying Routine Care Coverage in Trial Budgeting

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 27 Dec 2012 13:02:00 -0600

Thought Leaders: Jessica Dolfi, MS, Senior Business Consultant, Medidata Solutions Worldwide and Kelly Willenberg, MBA, BSN, CHRC, CHC, Kelly Willenberg, LLC

In this episode, we discuss standard of care in clinical trials, challenges for sites and sponsors, and how standard of care issues affect day-to-day work in trials.

For more information about Medidata Solutions Worldwide, visit www.mdsol.com.

Play Podcast.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Women's Health Issues in Clinical Research: Key Post-approval Challenges

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 16 Nov 2012 16:18:00 -0600

Thought Leaders: Jessica Albano, PhD, MPH, Senior Director, Epidemiology, Post Approval & Strategic Services, and Dr. Vikki Brown, Medical Director for the Post-Approval and Strategic Services division of INC Research, Inc.

In this episode, our experts discuss the primary challenges regarding women's health in clinical research. They also cover pregnancy registries and lactation studies, as well as available regulatory guidance related to this type of research.

For more information about INC Research, visit www.incresearch.com.

Play Podcast.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Informed Targeting to Healthcare Professionals

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 15 Nov 2012 15:13:00 -0600

Thought Leader: R.J. Lewis, President & CEO, eHealthcare Solutions

In this episode, Mr. Lewis discusses how pharma can better connect with HCP audiences using authentication, list matching, and other techniques. He also covers how effective communications can impact prescription writing, and how to overcome hurdles from Medical, Legal, and Regulatory (MLR) departments.

For more information about eHealthcare Solutions, visit www.ehealthcaresolutions.com.

Play Podcast.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Untangling Alzheimer's Disease

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 5 Oct 2012 13:34:00 -0500

Thought Leader: Prof. Claude Wischik, M.D., Ph.D., TauRx Therapeutics

In this episode, Professor Wischik describes his ongoing journey of research and development for Alzheimer's Disease. This intriguing podcast covers the man, the molecule, and the market.

For more information about TauRx Therapeutics, visit www.taurx.com.

Play Podcast.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

How to Tap the Pharmacy for Clinical Trial Patients

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 4 Oct 2012 07:49:00 -0500

Thought Leaders: Steve Hoffman, RPh, Chief Pharmacy Officer, McKesson Patient Relationship Solutions, Lynda Stout, PharmD, Lombard Health Mart Pharmacy

In this episode, our experts discuss pharmacy-based patient recruitment programs for clinical trials.

For more information about McKesson, visit www.mckesson.com.

Play Podcast.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

What are ACOs and Why Should You Care?

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 2 Oct 2012 07:45:00 -0500

Thought Leader: Anthony D. Slonim, MD, DrPH, Executive Vice President and Chief Medical Officer, Barnabas Health. Sponsored: by CMR Institute

In this episode, Dr. Slonim discusses ACOs, how they offer a new model for health care, how they create opportunities for biopharmaceutical companies, and how a shift to ACOs would affect all facets of the health care continuum.

For more information about CMR Institute, visit www.cmrinstitute.org.

Play Podcast.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Successful Email Marketing Methods: How to Boost Response by 400% or More

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 28 Sep 2012 09:10:00 -0500

Thought Leader: Terry Nugent, Executive Vice President, Sales and Marketing, MMS, Inc.

In this episode, Mr. Nugent discusses the challenges of using email in pharmaceutical marketing, as well as some best practices for achieving the highest possible ROI.

For more information about MMS, visit www.mmslists.com.

Play Podcast.

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Reaching Healthcare Providers While Remaining Compliant

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 31 Aug 2012 10:27:00 -0500

Thought Leader: Erez Lapsker, CEO, MediScripts

In this episode, Mr. Lapsker discusses how adaptability is necessary to remaining a viable and successful business in an era of regulatory change. He also explains how all forms of marketing to HCPs are not equal.

For more information about MediScripts, visit www.mediscripts.com.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Global Biosimilar Development

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 31 Aug 2012 10:22:00 -0500

Thought Leader: Rodeina Challand, Executive Director, Biosimilars Development, PRA International

In this episode, Rodeina Challand clears up some of the murkiness among the many terms associated with biosimilars. Then, we cover the legislation and guidelines affecting biosimilars, we discuss the possibilities of one global program, and finally talk about the future for a global standard.

For more information about PRA International, visit www.prainternational.com.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Future of Pharmacovigilance: Five Imperatives that will Drive Improved Business

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 31 Aug 2012 10:16:00 -0500

Thought Leaders: Nagaraja Srivatsan, SVP, Head of Life Sciences, North America at Cognizant Venkat Venkataramanan, Director, Pharmacovigilance Domain Head, Cognizant, George Botsakos, Senior Director and Life Sciences R&D Leader in Cognizant's Business Consulting group

In this episode, our panel discusses pharmacovigilance as it relates to organizational transformation. The podcast covers collaboration, capacity management, globalization, information and analytics, and transparency and trust.

For more information about Cognizant, visit www.cognizant.com.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Improve Adherence with Patient and Caregiver Support Programs

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 9 Jul 2012 14:10:00 -0500

Thought Leader: Lou Shapiro, Senior VP, Business Development, Tunstall AMAC Life Sciences

In this episode, Mr. Shapiro discusses why patient support programs are valuable, how to start a program, the necessity for delivering personalized information, several critical success factors for a program, and understanding health care from the patient's perspective.

For more information about Tunstall AMAC Life Sciences, visit www.phonescreen.com.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Influencing the Real Decision Makers: 7 Lenses For Marketing Health to Women

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 12 Jun 2012 07:12:00 -0500

Thought Leaders: Chris DeAngelis, VP, Sales, SSI and Jonathan Kay, Head of Healthcare, Penn Schoen Berland

In this episode, Taren Grom, Editor-in-Chief of PharmaVOICE, leads a discussion that focuses on a recent study on women's views and practices regarding health and health decisions for their families. The study uncovered seven lenses for marketing health to women. You'll come away with new insights into women's actual role as decision makers, caregivers, and medical and financial executives in their families. Plus, you will discover how to apply these new findings to create more effective marketing and market research programs for your brand or franchise.

For more information about SSI, visit www.surveysampling.com.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Understanding Patients in the Emerging Market of Russia

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 8 Jun 2012 09:31:00 -0500

Thought Leader: Gina Isherwood, Ph.D., Regional Brand Director, Kantar Health

In this episode, Dr. Isherwood shares some insightful research on the Russian people, including their health behaviors and attitudes, as well as the state of the health care system in Russia.

For more information about Kantar Health, visit www.kantarhealth.com.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Top Ten Patient Enrollment and Retention Myths

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 2 May 2012 13:59:00 -0500

Thought Leader: Scott Connor, VP of Marketing, Acurian

In this episode, Mr. Connor shares 4 of his top 10 myths about patient enrollment and retention, and we'll tell you where to get the entire list.

For more information about Acurian, visit www.acurian.com.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Patient Access to Investigational Drugs: Removing Barriers

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 12 Apr 2012 09:19:00 -0500

Thought Leader: Simon Estcourt, Senior VP, Strategy and Corporate Development, Idis

In this episode, Mr. Estcourt shares his perspective on programs that enable patient access to medicines outside the clinical trial or commercial setting and the barriers that remain despite well-defined regulations governing such access.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Insights from the Field: Tele-Sales Builds Relationships between Brand and HCPs

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 3 Apr 2012 11:08:00 -0500

Thought Leader: Lou Shapiro, Senior VP, Business Development, PhoneScreen, an AMAC company

In this episode, Mr. Shapiro describes his experiences working with companies on successful tele-detailing and tele-sales programs, including numerous insights on the unforeseen benefits of these solutions.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

DIA 2012 48th Annual Meeting Preview

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 28 Mar 2012 18:09:00 -0500

Thought Leader: Craig Lipset, DIA Conference Chair, Head of Clinical Innovation, Development Operations within Worldwide Research & Development, Pfizer

In this episode of the PharmaVOICE Executive Suite Podcast Series, Mr. Lipset shares his thoughts on being Chairman of the DIA 2012 48th Annual Meeting in June, and how his work at Pfizer helps him in his role with DIA including this year's theme on collaboration. He also comments on how industry trends will impact drug development and clinical trials, and offers a couple tips on getting the most out of this year's DIA Annual Meeting in Philadelphia.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Understanding the Impact of Drug Induced Liver Injury on Drug Development

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 2 Feb 2012 08:09:00 -0600

Thought Leader: Steve Lobel, PhD, D-ABMLI, MBA, FACB, Vice-president Global Laboratory Operations, PPD

In this episode, Dr. Lobel talks about Drug-induced liver injury, also known as DILI. We'll cover what DILI is, how it is identified, and its effects on the clinical development process. At the end of this podcast, you'll learn where you can download a related white paper on this topic.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The Evolving Social Media Lifecycle in Pharma

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 2 Feb 2012 08:05:00 -0600

Thought Leaders: Nagaraja Srivatsan, Dileep Srinivasan, and Alexander Gochtovtt, Cognizant

In this episode, a trio of experts from Cognizant talk about numerous issues involving social media in the life sciences. There is also a related white paper you may download.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

How the New Role of the CRO Affects Patient Enrollment

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 2 Feb 2012 08:03:00 -0600

Thought Leader: Richard Malcolm, CEO, Acurian

In this episode, Dr. Malcolm discusses how the role of the CRO is transitioning from commodity service supplier to strategic partner, and the unintended negative consequences this could have on what is already the most expensive part of clinical trials: patient enrollment.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Transformative Leadership

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 1 Feb 2012 17:02:00 -0600

Thought Leader: Dr. Deborah Dunsire, President and CEO, Millennium: The Takeda Oncology Company

In this episode, Dr. Dunsire shares her insights on the quest to find a cure for cancer, on women striving for positions in the C-Suite, and thoughts on her own career development and recognition as the 2009 HBA Woman of the Year.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Automating Pharma FCPA Due Diligence

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 4 Jan 2012 09:01:00 -0600

Thought Leader: Robert Shecterle, Vice President of Marketing, Aravo

In this episode, Mr. Shecterle discusses FCPA Compliance and anti-bribery practices at large pharmaceutical and life sciences companies.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The C-Suite: How Biotech Improves the Standard of Care of Patients

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 4 Jan 2012 08:55:00 -0600

Thought Leader: Brad Thompson, Ph.D., Chairman, President and CEO, Oncolytics Biotech

In this episode, Dr. Thompson talks about how biotech is making improvements in the standard of care, and the impact of Pharma 3.0. He also talks about his own experience taking REOLYSINÂ® through the drug development process, the genesis of Oncolytics Biotech, and shares some insights for biotech entrepreneurs.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Understanding How Social Networks Drive Healthcare Decisions: Mapping a New "Influence" Landscape

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 4 Jan 2012 08:52:00 -0600

Thought Leader: Chris DeAngelis, Vice President, Strategic Initiatives, SSI

In this episode, Mr. DeAngelis discusses a variety of issues regarding consumers' usage of social media for healthcare information. You'll learn some of the results of a study of over 1,400 U.S. consumers participating in proprietary panels and web communities.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Tele-detailing: Responding to Changing Pharma Sales Models

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 4 Jan 2012 08:50:00 -0600

Thought Leader: Lou Shapiro, Senior Vice President, AMAC Services Group and the PhoneScreen brand

In this episode, Mr. Shapiro talks about the challenges life science companies face when providing information on their products to physicians and healthcare providers.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Additive Patient Recruitment

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 3 Jan 2012 16:41:00 -0600

Thought Leader: Roger Smith, Senior Vice President, Operations, Acurian

In this episode, Mr. Smith talks about clinical trial enrollment and the concept of Additive Patient Recruitment.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

iTunes Cover Art

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 16 Nov 2011 14:32:00 -0600

Understanding Patients in the Emerging Market of Brazil

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 16 Nov 2011 13:54:00 -0600

Date Posted: 11/10/2011
Size: 6.89MB
Length: 00:15:03
Thought Leader: David Pomerantz, Senior Vice President, Business Development, Kantar Health

In this episode, Mr. Pomerantz talks about the influence of patients in pharma and especially in emerging markets such as Brazil.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Planning for Clinical Trial Conduct in Emerging Locations

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 16 Nov 2011 13:51:00 -0600

Date Posted: 9/28/2011
Size: 6.4MB
Length: 00:14:07
Thought Leader: Kelly Larrabee, RN, MBA, MS, Senior Director, Clinical Services, ClearTrial

In this episode Ms. Larrabee discusses clinical trials in emerging countries, and the major planning challenges, plus how collaborative partnerships are helping in the search for new treatments. For more information about ClearTrial, visit http://www.cleartrial.com/.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Keys to Partnering with a Pharmaceutical Call Center

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 16 Nov 2011 13:49:00 -0600

Date Posted: 9/13/2011
Size: 4.67MB
Length: 00:10:13
Thought Leader: Lou Shapiro, Senior Vice President, AMAC Services Group and the PhoneScreen brand

In this episode, Mr. Shapiro shares his views on how pharmaceutical, biotech, and medical device companies can benefit from partnering with a qualified pharmaceutical call center. For more information about PhoneScreen, visit http://www.phonescreen.com/.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Leveraging Customer Insights to Maximize ROI

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 16 Nov 2011 13:47:00 -0600

Date Posted: 8/31/2011
Size: 6.17MB
Length: 00:13:29
Thought Leaders: Jay Bolling, President & CEO, Chuck McLeester, SVP Planning, Metrics & Analytics, Kurt Mueller, Chief Digital & Science Officer, Roska Healthcare Advertising

In this episode, the team at Roska Healthcare discusses new ways to use behavioral and attitudinal data to enhance customer targeting and messaging. They review a unique, new communications model (Catalyst-tm) that increases customer 'acceptance' (engagement) and drives more people to take action.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Mentoring: A Professional Advantage

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 16 Nov 2011 13:44:00 -0600

Date Posted: 8/12/2011
Size: 6.17MB
Length: 00:13:29
Thought Leader: Laurie Cooke, CEO, Healthcare Businesswomen's Association

In this episode, Ms. Cooke discusses what it means to be honored as Mentor of the Year, why mentoring is an important career development strategy, and the HBA's commitment to helping its members develop their careers through mentoring and coaching.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Understanding the Power of KOL Influence Mapping

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 16 Nov 2011 13:42:00 -0600

Date Posted: 6/27/2011
Size: 6.37MB
Length: 00:13:55
Thought Leader: Gary Bartolacci, Senior Account Director, Kantar Health

In this episode, Mr. Bartolacci discusses the power of key opinion leaders nationally, regionally, and locally. He explains how pharmaceutical companies can achieve stronger results using influence mapping, various approaches to influence mapping (including the benefits and risks of these studies) and best practices, along with addressing clients' most common questions.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Clinical Supply Optimization: Challenges & Solutions

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 16 Nov 2011 13:40:00 -0600

Date Posted: 5/31/2011
Size: 7.8MB
Length: 00:17:03
Thought Leader: Steven Yoder, Director, Client Services, Fisher Clinical Services

In this episode, Mr. Yoder discusses the challenges and benefits of clinical supply optimization and what the future looks like as companies strive to achieve a balance between optimization and cost-reduction.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Networked Drug Development - Bringing Assets, Capital and Services Together

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 16 Nov 2011 13:38:00 -0600

Date Posted: 5/31/2011
Size: 5.56MB
Length: 00:12:09
Thought Leader: Tim Dietlin, VP of Alliance Development, INC Research

In this episode, Mr. Dietlin discusses a burgeoning concept called the Networked Drug Development Alliance, what it is, what's driving it, and how they improve the process for pharmaceutical companies and investors.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Improving Safety, Security, and Speed using Voice Biometrics

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 16 Nov 2011 13:35:00 -0600

Date Posted: 4/29/2011
Size: 7.95MB
Length: 00:17:23
Thought Leader: Richard Scarbath , Director, Enterprise Accounts, Angel

In this episode, Mr. Scarbath discusses the movement into voice biometrics for voice signatures and authentication. He provides a general overview of the technology and how it is being applied in the pharmaceutical industry and sampling world..

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The Undercalculated Costs Driving Today's Clinical Trials

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 16 Nov 2011 13:33:00 -0600

Date Posted: 4/29/2011
Size: 12.0MB
Length: 00:26:17
Thought Leader: Ian Hunter, Global Account Director, Fisher Clinical Services

In this episode, Mr. Hunter, discusses the many variables and issues surrounding transportation and distribution of product for global clinical trials.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Oncology Trials: A Novel Approach to Patient Accrual

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 7 Apr 2011 17:05:00 -0500

Date Posted: 3/30/2011
Size: 5.95MB
Length: 00:13:02
Thought Leader: Ed Watson, Director of Oncology, Acurian, Inc.

In this episode, Ed Watson discusses some of the challenges associated with recruiting for clinical studies in oncology, the roles of various key stakeholders, and the sponsor community's response to a new approach to patient accrual.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Streamlining Clinical Trials with an Approved Phrase Library for Labeling

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 7 Apr 2011 17:04:00 -0500

Date Posted: 3/24/2011
Size: 7.68MB
Length: 00:16:32Thought Leader: Kevin Shea, Label Program Director, Clintrak Clinical Labeling Services LLC., a part of Thermo Fisher Scientific

In this episode, Mr. Shea discusses how clinical trials are affected by label text issues, streamlining the process with a phrase library, and the advantages of managing a phrase library with a dedicated system.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Why ISMPP?: Leadership, Value, and Best Practices for Medical Publication Professionals

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 7 Apr 2011 17:02:00 -0500

Date Posted: 3/4/2011
Size: 6.78MB
Length: 00:14:49
Thought Leaders: Kim Goldin, Executive Director, Julia Ralston, President, and Robert Norris, Past President, ISMPP

In this episode, our thought leaders discuss what ISMPP is and how it's evolved, how the organization can help Medical Publication Professionals, and the 2011 annual meetings in the US in April and in Europe in November.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Building a Communications Bridge: A Best Practice for Conducting Clinical Trials in India

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 7 Apr 2011 17:00:00 -0500

Date Posted: 3/1/2011
Size: 7.4MB
Length: 00:16:10
Thought Leaders: Dr. James A. Bannon, Executive Chairman and Dr. Edward J. Brennan, Jr. President and CEO, IndiPharm

In this episode, Dr. Bannon and Dr. Brennan discuss conducting clinical trials in India. They cover why a seamless communication strategy is important, how an in-country partner can improve the trial outcome, regulatory issues in India, and the ROI of conducting clinical trials in India.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

A New Wellness-Centric Ecosystem

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 7 Apr 2011 16:58:00 -0500

Date Posted: 1/31/2011
Size: 4.63MB
Length: 00:10:07
Thought Leaders: Nagaraja Srivatsan, Senior VP and Head of Life Sciences, North America and Dr. Elby Nash, Principal, Cognizant Business Consulting, Life Sciences, Cognizant

In this episode, Srivatsan and Dr. Nash discuss a forward-thinking business model that focuses on overall patient wellness and preventative medicine rather than simply treating illness.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Best Practices for Your CRO Partnerships

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 7 Apr 2011 16:56:00 -0500

Date Posted: 1/31/2011
Size: 8.04MB
Length: 00:17:34
Thought Leader: Colin Terry, Executive Vice President, Commercial Operations, Aptuit

In this episode, Mr. Terry shares his perspective on how drug developers can move beyond the typical, transactional, approach to outsourcing and instead, create true partnerships with their CROs that reflect a commitment to a shared development vision.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

How Integrated Solutions Can Optimize Clinical Research

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 7 Apr 2011 16:51:00 -0500

Date Posted: 1/31/2011
Size: 5.97MB
Length: 00:13:03
Thought Leader: James DeSanti, CEO, PharmaVigilant

In this episode, Mr. DeSanti discusses Integrated Solutions in clinical research. We define the concept, outline how sponsors can utilize it, and finally, we cover the benefits and ROI of an integrated approach.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Unveiling the Potential of the CEE Market

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 7 Apr 2011 16:49:00 -0500

Date Posted: 1/31/2011
Size: 8.78MB
Length: 00:19:11
Thought Leader: Pali F. Kollath DVM, MBA Regional Director, Central & Eastern Europe and Treatment Value Practice, Kantar Health

In this episode, Pali F. Kollath discusses Central and Eastern Europe as an emerging market for pharmaceutical companies. You'll learn how large this market is, the benefits of moving into this market, some of the risks and challenges, best practices for setting up operations, and where the market is heading in the future.

Play Podcast

Download transcript and white paper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

China: An Emerging Market for Cancer Therapeutics

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 4 Jan 2011 14:35:00 -0600

Date Posted: 12/30/2010
Size: 6.12MB
Length: 00:13:48
Thought Leader: Richard Wagner, Ph.D., Senior Director, Kantar Health
In this episode, Dr. Wagner talks about China as an emerging market for cancer drugs, including the differences between the U.S. and China in terms of access to testing and drugs, as well as differences in healthcare coverage. We'll also discuss some of Kantar's latest research on cancer in China.

Play Podcast

Download transcript and white paper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Improving Clinical Research ROI using Remote Source Document Verification

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 27 Dec 2010 11:40:00 -0600

Date Posted: 12/17/2010
Size: 4.92MB
Length: 00:10:45
Thought Leader: James DeSanti, CEO, PharmaVigilant

In this episode, Mr. DeSanti discusses remote source document verification, also known as rSDV. First we'll define rSDV, and then talk about the benefits, challenges, and the ROI of implementing rSDV, as well as other issues.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Streamlining Clinical Research with Electronic Trial Master Files

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 2 Nov 2010 08:51:00 -0500

Date Posted: 9/30/2010
Size: 7.93MB
Length: 00:17:19
Thought Leader: James DeSanti, CEO, PharmaVigilant

In this episode, Mr. DeSanti discusses the clinical trials trend of moving to an Electronic Trial Master File platform. He covers the strategic and practical aspects of making the move, and what the payback is for doing so.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

An Integrated Approach to Comparator Sourcing and Supply Chain Management Solutions

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 2 Nov 2010 08:48:00 -0500

Date Posted: 9/30/2010
Size: 7.93MB
Length: 00:17:19
Thought Leader: Dr. Philippe Muller, Managing Director Manufacturing and Comparator Services, Fisher Clinical Services

In this episode, we'll discuss using comparator drugs in clinical trials, and overcoming the issues and challenges of using comparators.

Play Podcast

Download related whitepaper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Moving Medical Affairs to the Cloud Proves to be a Very Down-to-Earth Strategy for AstraZeneca

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 2 Nov 2010 08:45:00 -0500

Date Posted: 9/24/2010
Size: 6.22MB
Length: 00:13:35
Thought Leaders: John Pelkowski, Senior Director of Client Engagement for Medical Affairs, AstraZeneca and Kevin Krause, Senior Director of Medical Affairs, Strategy & Operations, AstraZeneca

In this episode, we'll discuss AstraZeneca's recent move to the cloud. The company switched from an on-premise, custom-developed CRM system to Veeva Systems' multi-tenant SaaS CRM system.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Best Practices for Sites and CRO Collaboration

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 1 Nov 2010 16:12:00 -0500

Date Posted: 07/29/2010
Size: 6.64MB
Length: 00:14:31
Thought Leaders: Ed Jahn, Clinical Operations Specialist, Criterium and Jaime Campbell Hudak, Clinical Data Liaison II, Criterium

In this episode, our thought leaders discuss ways for CROs and sites to work together to achieve the best possible results. This episode is chock full of best practices and tips, as well as an overview of the results of a July 2010 survey of sites.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The Global Strategic Partner Model as a Key Enabler in Clinical Transformation

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 3 Jun 2010 08:02:00 -0500

Date Posted: 6/1/2010
Size: 5.5MB
Length: 00:11:59
Thought Leaders: Nagaraja Srivatsan, Vice President, Head of Life Sciences, North America, Cognizant, Ramana Reddy, Practice Leader Life Sciences, Cognizant Business Consulting, Krishnan Rajagopalan Ph.D., Global Head of Life Sciences BPO, Cognizant

In this episode, we'll discuss the current state of R&D in the pharmaceutical industry, the ongoing transformation of clinical operations and how the global strategic partner model is facilitating many of these changes.

Play Podcast

Download Whitepaper

Download Transcript

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Understanding Cloud Computing for CRM

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 3 Jun 2010 07:58:00 -0500

Date Posted: 6/1/2010
Size: 6.47MB
Length: 00:14:09
Thought Leader: Matt Wallach, Executive VP and General Manager, Veeva Systems

In this episode, Mr. Wallach discusses how pharmaceutical companies can benefit from Software as a Service and Cloud Computing to improve the sales process within the life-sciences industry.

Play Podcast

Download Transcript

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

U.S. and Global Information Security Standards in Patient Recruitment

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 26 May 2010 09:06:00 -0500

Date Posted: 05/17/2010
Size: 4.1MB
Length: 00:8:58
Thought Leader: Roger Smith, Senior VP, Operations, Acurian Inc.

In this episode, Mr. Smith provides detailed information related to security standards in patient recruitment, what clinical teams need to consider when selecting the right recruitment partner, and how to navigate and understand the complex guidelines and regulations in this space.

Play Podcast

Download Whitepaper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Clinical Delivery Alliances in Drug Development

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 26 May 2010 09:03:00 -0500

Date Posted: 05/11/2010
Size: 6.88MB
Length: 00:15:02
Thought Leader: Tim Dietlin, VP of Alliance Development, INC Research

In this episode Mr. Dietlin talks about Clinical Delivery Alliances; what they are and how they can benefit the drug development process.

Play Podcast

Download Whitepaper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Industry Experts Weigh in on Marketing Research after PMRG

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 26 May 2010 09:00:00 -0500

Date Posted: 05/1/2010
Size: 10.9MB
Length: 00:23:55
Thought Leaders: Debbie Kossman, Senior VP, National Analysts Worldwide, and the 2010 President of PMRG, Juliana Mastroserio, Director or Marketing Research, Johnson & Johnson, Lynnette Cooke, CEO, Kantar Health

In this episode we'll cover various topics pertaining to marketing research in the pharmaceutical industry. We have three distinguished thought leaders who represent different perspectives on marketing research, and offer some takeways from the 2010 PMRG Annual Conference.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Leveraging Expanded Access and Named-Patient Programs: Best Practices for Small and Emerging Biotech and Pharma Companies

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 8 Apr 2010 08:56:00 -0500

Date Posted: 03/31/2010
Size: 6.64MB
Length: 00:14:32
Thought Leader: Nicky Wisener, Biopharmaceutical Account Manager, Idis

In this episode, Ms. Wisener describes how expanded access and named-patient programs can help successfully meet patients' needs while addressing the unique challenges faced by smaller and emerging companies.

Play Podcast

Download Whitepaper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Brand Stewardship: Best Practices for Maintaining Creative Integrity and Client Services

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 8 Apr 2010 08:53:00 -0500

Date Posted: 03/29/2010
Size: 8.40MB
Length: 00:18:21
Thought Leaders: Tammy Fischer, President, GSW Worldwide in New York and Bruce Rooke, Chief Creative Officer, GSW Worldwide

In this episode, Ms. Fischer and Mr. Rooke discuss best practices for brand stewardship and how to maintain creative integrity. They cover the issues as they relate to the client, the consumer, and the agency.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Social Networking for Patient Recruitment for Clinical Trials

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 8 Apr 2010 08:50:00 -0500

Date Posted: 03/18/2010
Size: 5.77MB
Length: 00:12:36
Thought Leader: Scott Connor, VP of Marketing, Acurian

In this episode, Mr. Connor describes how social networking can be used as a powerful business tool for patient recruitment for clinical trials.

Play Podcast

Download Whitepaper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Modernizing Incentive Compensation Plans

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 8 Apr 2010 08:48:00 -0500

Date Posted: 03/16/2010
Size: 7.46MB
Length: 00:16:19
Thought Leader: Stephen M. Fox, Global Practice Leader, Sales Performance Center of Excellence, IMS Management Consulting

In this episode, Mr. Fox discusses incentive compensation plans in the pharmaceutical industry, why the incumbent plans aren't working, and how new solutions have emerged that improve the accuracy and efficiency of plans.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Standards for Industry-Sponsored Studies and Journal Publication Planning

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 8 Apr 2010 08:37:00 -0500

Date Posted: 03/12/2010
Size: 6.53MB
Length: 00:14:16
Thought Leaders: Bernadette Mansi, Scientific Communications Strategy Head, Cardiovascular, Metabolism and Ophthalmology, GlaxoSmithKline, and Dr. Trish Groves, Deputy Editor, British Medical Journal

In this episode we cover the Medical Publishing Insights and Practices (MPIP) initiative, a relatively new development co-sponsored by Amgen, AstraZeneca, GlaxoSmithKline, Pfizer and the International Society for Medical Publication Professionals (ISMPP). Ms. Mansi and Dr. Groves discuss what MPIP is, who is behind the initiative, its goals and accomplishments, and how the pharmaceutical industry and journal editors and publishers are benefitting from collaboration on standards to elevate trust and transparency in publishing industry-sponsored studies. The latest undertaking is the creation of an Authors' Submission Toolkit: A Practical Guide to Getting Your Research Published, being rolled-out at the 6th Annual Meeting of ISMPP, April 19-21, Arlington, VA. To learn more and register, please visit http://www.ismpp.org.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Commercial Compliance for Pharmaceutical and Medical Device Companies

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 2 Mar 2010 08:19:00 -0600

Date Posted: 02/22/2010
Size: 5.62MB
Length: 00:12:17
Thought Leader: Daniel Garen, Chief Compliance Officer and Senior Counsel, Siemens Healthcare Sector, USA

In an exclusive interview with PharmaVOICE, Mr. Garen shares his expertise and insights on a variety of commercial compliance issues, including The Sunshine Act, Healthcare Reform, the Foreign Corrupt Practices Act (FCPA), and how companies can create a culture of compliance through proactivity. Mr. Garen is also the keynote speaker at the upcoming Marcus Evans' Commercial Compliance for Pharmaceutical and Medical Device Companies Conference, April 12-13, Washington, D.C. For more information about the conference, please go to: http://www.marcusevansch.com/commericalcompliance.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Leveraging Digital Technology in Pharmaceutical Marketing: A New Agency Model

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 2 Mar 2010 08:14:00 -0600

Date Posted: 01/19/2010

Size: 6.95MB

Length: 00:15:11
Thought Leaders: Kurt Holstein, Co-Founder and President, Rosetta, and Steven Michaelson, Founder and CEO, Wishbone

Mr. Holstein and Mr. Michaelson discuss the benefits and challenges of the new agency model that has emerged with the growth of digitally enabled communications.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Performance-based Pricing in Patient Recruitment

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 1 Dec 2009 18:08:00 -0600

Date Posted: 12/01/2009

Size: 14.4MB

Length: 00:14:04
Thought Leader: Richard Malcolm Ph.D., CEO, Acurian

Dr. Malcolm talks about risk sharing and performance-based pricing as a way for sponsors to get the best results for their patient recruiting budget.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Podcast Overview

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 30 Oct 2009 15:24:00 -0500

A 5-minute overview on Podcasts.

http://www.zentation.com/viewer/index.php?passcode=vZyD7tfRw5

Learn how PharmaVOICE produces, promotes, and distributes podcasts, and how to maximize exposure for your thought leaders to the pharmaceutical industry.

The Evolution of the E-Patient

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 1 Oct 2009 00:05:00 -0500

Date: 10/01/2009

Length: 00:20:13

Size: 9.25MB

Thought Leader: Bonnie Brescia, Founding Principal, BBK Worldwide

Ms. Brescia provides an overview of the e-patient, how this special patient population can be leveraged for clinical trial participation, and how social media are impacting recruitment and clinical research.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Return On Investment in Patient Recruitment

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 1 Sep 2009 09:13:00 -0500

Date: 09/01/2009

Length: 00:22:47

Size: 10.4MB

Thought Leader: Richard Malcolm Ph.D., CEO, Acurian

Dr. Malcolm talks about planning and measuring return on investment in patient recruitment today, as well as what the future holds in this area.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Commercial Operations Outsourcing: A Leading-edge Response to the Financial Storm Affecting the Life-sciences Industry

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 1 Sep 2009 09:12:00 -0500

Date: 08/01/2009

Length: 00:17:26

Size: 12.31MB

Thought Leaders: Jassi Chadha, Head of Analytics Practice, Cognizant, Patrick Brundage, Practice Leader, Life Sciences Analytics, Cognizant, and Nagaraja Srivatsan, VP and Head of Life Sciences, North America, Cognizant

In this special PharmaVOICE 100 podcast, our thought leaders discuss the current state of the life-sciences industry, the changes it is experiencing now, and what the industry will look like in the next decade.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

The Digital Wave – Delivering Education and Services to Healthcare Providers

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 1 Sep 2009 09:07:00 -0500

Date: 08/01/2009

Length: 00:11:50

Size: 5.41MB

Thought Leader: Donato Tramuto, CEO and Vice Chairman, Physicians Interactive

In this special PharmaVOICE 100 podcast, Mr. Tramuto discusses digital technologies that educate and provide important services to healthcare providers to improve communication and help deliver better patient outcomes.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

The State of Women in Healthcare

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 1 Sep 2009 09:03:00 -0500

Date: 08/01/2009
Length: 00:16:53
Size: 7.75MB

Thought Leader: Laurie P. Cooke, R.Ph., CEO, Healthcare Businesswomen's Association (HBA)

In this special PharmaVOICE 100 podcast, Ms. Cooke outlines the current state of women in healthcare, discusses the importance of mentoring, and shares her views on volunteerism. This episode also provides an overview of the HBA and its upcoming Annual Leadership Conference — Limitless Leadership: Bridging Today, Tomorrow, and Beyond — in November 2009.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Science is Greater than the Economy

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 9 Jun 2009 11:15:00 -0500

Date: 05/29/2009
Length: 00:11:46
Size: 5.38MB

Thought Leaders: Lawrence Reiter, Ph.D., Director of Global Affairs, Criterium Inc.

Dr. Reiter discusses why it’s important to maintain R&D spending during fiscally challenging times, the pros and cons of a global R&D plan, how to do more with less, what technology brings to the table, and other critical factors to improve the development process.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Charting a New Course by Catalyzing Transformation

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 9 Jun 2009 11:12:00 -0500

Date: 05/28/2009
Length: 00:14:56
Size: 6.84MB

Thought Leaders: Adrian McKemey, Ph.D. Managing Director, Quintiles Consulting
Michael Arlotto, Ph.D., Senior Vice President, Quintiles Corporate Development.

In episode three, of a three-part series, “Surviving to Thriving in Stormy Weather,” our thought leaders discuss declining R & D productivity combined with increasing development costs. They offer insights and solutions to maximizing efficiencies and effecting change within R & D organizations in the biopharma industry.

Play Podcast

Download Related Whitepaper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

How to Connect Patients and Physicians Around Your Brand

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 9 Jun 2009 11:09:00 -0500

Date: 05/27/2009
Length: 00:17:57
Size: 8.22MB

Thought Leaders: Michael Ball, Ph.D., VP of Marketing, InfoMedics
Paul LeVine, VP of Analytical Services, InfoMedics

In this episode, Dr. Ball and Mr. LeVine discuss the importance of patient feedback – how to obtain it and how it can be used to better connect brands with patients and physicians in a practice setting.

Play Podcast

Download Related Whitepaper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Connecting through Electronic Health Records

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 9 Jun 2009 11:07:00 -0500

Date: 05/26/2009
Length: 00:14:41
Size: 6.72MB

Thought Leaders: Landen Bain, Liaison to Healthcare, CDISC
Dave Iberson-Hurst, VP of Technical Strategy, CDISC

In this episode, Mr. Bain and Mr. Iberson-Hurst discuss CDISC’s efforts in instituting standards for Electronic Health Records and RFD - Retrieve Form for Data Capture. They also cover where the organization’s efforts will be applied in the future.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Making Headway in Shifting Winds by Maximizing Value

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 9 Jun 2009 11:01:00 -0500

Date: 5/01/2009
Length: 00:19:08
Size: 8.76MB

Thought Leaders: James Featherstone, Ph.D., VP of Product Development and Commercialization for the EU, Quintiles Consulting, Bruce E. Johnson, Ph.D., Senior Research Director, Eidetics, a division of Quintiles Consulting, and Heidi Hunter, Global VP, Business Development, Quintiles

In episode two, of a three-part series, "Surviving to Thriving in Stormy Weather," our thought leaders discuss new commercialization processes as healthcare moves towards personalized medicine. They also cover how to assess market potential for personalized therapies, post-launch sales strategies for niche drugs, and finally, meeting the needs of global and regional markets for these types of therapies.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Better Standards and Metrics for CROs and Sponsors

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 30 Apr 2009 09:38:00 -0500

Date:4/08/2009
Length: 00:14:29
Size: 6.63MB
Thought Leaders:
Gregg Dearhammer, President, i3 Statprobe
Karen Goss, Global Director, Pharmacovigilance, i3 Drug Safety

In this episode, Mr. Dearhammer and Ms. Goss discuss the need for metrics and standards for clinical trials management and the impact of the Metrics Champion Consortium (MCC) on CROs and sponsors.

Play podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Setting Sail for Success by Optimizing Productivity

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 2 Apr 2009 10:19:00 -0500

Date:4/01/2009
Length: 00:14:31
Size: 6.64MB

Thought Leaders: Michael Hagan, Principal Consultant, Quintiles Consulting and James C. Kirk, VP and Practice Leader, Eidetics, Quintiles Consulting

In episode one, of a three-part series, “Surviving to Thriving in Stormy Weather,” Mr. Hagan and Mr. Kirk discuss market pressures and how economic turmoil in the biopharma industry can be overcome by using process optimization.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Overcoming Global Marketing and Regulatory Challenges

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 12 Mar 2009 08:50:00 -0500

Date:3/02/2009
Length: 00:012:37
Size: 5.77MB

Thought Leaders: John Doyle Dr.P.H., Managing Director and Practice Leader, Market Access, Quintiles Consulting, and Geoff Garabedian, Managing Director and Practice Leader, Regulatory, Quintiles Consulting

In this episode, Dr. Doyle outlines cost-based evaluation and market-access strategies based on comparative effectiveness and safety research. Then Mr. Garabedian talks about the impact of regulatory globalization, and finally, there is a discussion covering the latest pharmaceutical initiatives from the European Commission, and how these will impact the global healthcare industry.

Play P0dcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Global Clinical Trials Outsourcing: New Tips and Trends

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 12 Mar 2009 08:48:00 -0500

Date:3/02/2009
Length: 00:012:25
Size: 5.68MB

Thought Leader: Patrick Durbin, VP, Fisher Clinical Services (a division of Thermo Fisher Scientific)

In this episode, Mr. Durbin offers some best practices for developing a strategic partnership with outsourcing providers, discusses some of the biggest challenges and missteps in global clinical trials outsourcing, covers emerging opportunities at the global level, and lists some of the most important emerging trends in this arena.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Driving Sales Force Effectiveness in Turbulent Times

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 12 Mar 2009 08:47:00 -0500

Date:2/23/2009
Length: 00:011:51
Size: 5.42MB

Thought Leader: Brett Knowles, Founder, Performance Measurement and Management

In this episode, Mr. Knowles discusses an actionable approach to boosting sales force performance, and how it has delivered results for Pharmaceutical companies in today's challenging environment.

Free Whitepaper Paper for download: Five Steps to Pharma Sales Force Effectiveness Click Here

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Pharmaceutical Forecasting Insights: The Process, Hurdles, and Important Trends

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 12 Mar 2009 08:44:00 -0500

Date:1/30/2009
Length: 00:013:28
Size: 6.16MB

Thought Leader: Todd Johnson, Director of Forecasting, MattsonJack

In this episode, we discuss the importance and benefits of having an effective forecasting process, hurdles to implementation, available tools, and trends in the forecasting arena, particularly oncology forecasting. MattsonJack is holding a live workshop on forecasting in Scottsdale, AZ March 19-20. The workshop offers best practices, real-world tips and expert advice. To learn more about this important event Click Here.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

John Crowley’s Personal Crusade

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 12 Mar 2009 08:43:00 -0500

Date:12/30/2008
Length: 00:07:18
Size: 3.34MB

Thought Leader: John Crowley, President and CEO, Amicus Therapeutics

In this episode, Mr. Crowley shares his personal journey to find viable treatements for Pompe disease, a condition which two of his children are afflicted. His amazing story is also showcased in the January issue of PharmaVOICE.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Understanding the New PhRMA Code for Medically Relevant Items

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 12 Mar 2009 08:40:00 -0500

Date:12/30/2008
Length: 00:13:00
Size: 5.95MB

Thought Leader: David Ganz, Managing Director, Total Health Rewards

In this episode, Mr. Ganz discusses the new PhRMA code as it relates to medically relevant items (MRIs) and how companies can stay compliant with this new guideline.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157

Critical Care Opportunities in a Global Arena

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 15 Dec 2008 10:04:00 -0600

Date:12/15/2008
Length: 00:12:05
Size: 5.50MB
Thought Leader: Clive Meanwell, M.D., PhD., Chairman and CEO, The Medicines Company

In this episode we talk about moving from a US focused to a globally focused company. We discuss several factors impacting the global pharmaceutical and healthcare market, and how outcomes research will be used in the future in the US and ex-US

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Demystifying Social Media — It's Not About Controlling the Message

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 20 Nov 2008 14:14:00 -0600

Date:11/19/2008
Length: 00:11:56
Size: 5.46MB
Thought Leader: Ken Ribotsky, President and CEO, Core-Create

In this episode, Mr. Ribotsky discusses the relatively new web phenomenon called Social Media – what it is and how it can be used for improving brand messaging and communications.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Achieve Optimal Messaging for Your Inline Brand

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 20 Nov 2008 14:14:00 -0600

Date:11/19/2008
Length: 00:16:21
Size: 7.48MB
Thought Leader: Ian McKinnon Ph.D., Senior Vice President, TNS Healthcare

In this episode, Dr. McKinnon discusses how brand teams can optimize their messages, evaluate their messengers (sales reps), and minimize the damage from competing messages in their market space.

Play Podcast

Download Related Presentation

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

The Benefits and Challenges of Creating Personalized Brand Dialogue Between Physicians and Patients

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 20 Nov 2008 14:13:00 -0600

Date:11/19/2008
Length: 00:17:28
Size: 8.00MB
Thought Leaders: Paul LeVine, VP Analytical Services, InfoMedics and Dr. Stanley Wulf, Chief Medical Officer, InfoMedics

In this episode, Mr. LeVine and Dr. Wulf discuss ways to improve the dialog between physicians and patients using personalized data and communication tools in an effort to increase patient retention and health outcomes.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Procuring and Managing Clinical Staffing Resources

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 20 Nov 2008 14:12:00 -0600

Date:11/19/2008
Length: 00:15:03
Size: 6.89MB
Thought Leader: Stephen Cottrell, Executive V.P. of Operations and Business Development, inVentiv Clinical Solutions

In this episode, Mr. Cottrell outlines many of the challenges in procuring and managing clinical staffing resources, and offers advice on how to overcome them.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Ensuring Launch Success: Payer and Prescriber Considerations in

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 20 Nov 2008 14:11:00 -0600

Thought Leader: Sarah Rickwood, Senior Principal, IMS

Play Podcast

Link to Related Videocast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Fresh Approaches to Launch Success

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 20 Nov 2008 14:09:00 -0600

Thought Leader: Robert Harold, Senior Principal, IMS

Play Podcast

Link to Related Videocast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Winning in the Dynamic Market: Novel Approaches

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 20 Nov 2008 14:09:00 -0600

Thought Leader: Lisa Morris, Global APLD Services, IMS

Play Podcast

Link to Related Videocast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

The Dynamic Market: Why It's the Most Important Area of Focus for Your Brand

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 20 Nov 2008 14:08:00 -0600

Changing the Game: New Opportunities in the Dynamic Market

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 20 Nov 2008 14:07:00 -0600

A Dual-Degree MSPharm/MBA Online Program Update

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 20 Nov 2008 14:05:00 -0600

Date:10/17/2008
Length: 00:07:52
Size: 3.60MB
Program Representative: David B. Brushwood, R.Ph., J.D., Professor of Pharmaceutical Outcomes and Policy, University of Florida

In this episode, Professor Brushwood provides an update on a new online dual-degree program: a Master of Science in Pharmacy degree from the University of Florida and a Master of Business Administration from Stetson University. He discusses the benefits of the dynamic dual-degree, the program structure, the advantages of an online program, and admission requirements. Current registration period ends after November 1, 2008.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

eClinical Moves into the Mainstream

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 29 Sep 2008 13:51:00 -0500

Date:9/11/2008
Length: 00:13:28
Size: 6.17MB

Thought Leader: Stacey Arrambide, VP, Statistics and Data Management, inVentiv Clinical Solutions

In this episode, Stacey Arrambide shares her insights about the eClinical arena -- how it has evolved and what the benefits are, particularly regarding cost savings.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

Fighting Back: Technology Solutions to the Counterfeit Drug Problem

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 29 Sep 2008 13:48:00 -0500

Date: 9/22/2008
Length: 00:15:56
Size: 7.29MB
Thought Leader: MaryAnn Hegedus, Business Development Manager, Colorcon

In this episode, Ms. Hegedus discusses the implications of the counterfeit drug market, and offers insights on how companies can use authentication technologies to protect their revenue, enable security throughout the entire supply chain at the dosage level, and improve consumer confidence.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157 .

The Pharma-Physician-Patient Connection: Working Together to Improve Treatment Outcomes

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 29 Sep 2008 13:41:00 -0500

Date: 9/8/2008
Length: 00:14.49
Size: 6.78MB

Thought Leaders:
Dr. Stanley Wulf, Chief Medical Officer, InfoMedics
Ray Bullman, Executive VP of NCPIE (National Council on Patient Information and Education)

In this episode, our thought leaders share insights on improving treatment outcomes through patient adherence programs, including best practices and a look into the future of adherence programs.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Molecular Design and the Critical Path Problem

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 11 Sep 2008 09:02:00 -0500

Date:9/08/2008
Length: 00:16:35
Size: 7.59MB

Thought Leader: Stephen Byrn, Ph. D., Charles B. Jordan Professor of Medicinal Chemistry and Head of the Department of Industrial and Physical Pharmacy, Purdue University; and Head of the Aptuit Scientific Advisory Board

In this episode, Dr. Byrn speaks about the critical path problem in drug development and how a designed molecular delivery system can improve the drug development process.

Play Podcast

Download free related whitepaper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

E-Clinical: Driving Efficiencies and Reducing Costs for Drug Development

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 31 Jul 2008 10:20:00 -0500

Date:7/30/2008
Length: 00:16:44
Size: 7.66MB
Thought Leader: Chris Porter, Cofounder and Chief Operating Officer, Clinipace

In this episode, Taren Grom, Editor, PharmaVOICE, speaks with 2008 PharmaVOICE 100 honoree Chris Porter about the need for a better clinical model, one driven by affordable technology and software solutions, as well as best practices to improve clinical research processes.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Insights on Developing a Career Path in the New Era of the Life Sciences

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 31 Jul 2008 10:18:00 -0500

Date:7/30/2008
Length: 00:15:08
Size: 6.93MB
Thought Leader: Howard Weisman, CoFounder, CEO, and Chairman, EKR Therapeutics Inc.

In this episode, Taren Grom, Editor, PharmaVOICE, speaks with Mr. Weisman, a 2008 PharmaVOICE 100 honoree, about how to maximize career opportunities in the pharmaceutical industry and how the career paths are changing.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Mobile Devices: Connecting Physicians and Pharma

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 18 Jul 2008 16:40:00 -0500

Date:7/15/2008
Length: 00:10:38
Size: 4.87MB
Thought Leader: Sandeep Shah, President and Founder, Skyscape

In this episode, Taren Grom, Editor, PharmaVOICE, speaks with Mr. Shah about the importance of wireless mobile devices to physicians and how pharmaceutical companies can leverage this platform for physician communications.Free Report: Effect of PDA-Based Information on Treatment Decisions

Play Podcast

Download Related Free Report

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Patient Journey Marketing™ and the Power of Video

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 18 Jul 2008 16:40:00 -0500

Date:7/8/2008
Length: 00:17:52
Size: 8.32MB
Thought Leader: Liz Kay, VP, Account Services, Healthcare Practice, Cramer

In this episode, Liz Kay discusses the use of online video as an effective and interactive medium for patient communications.Whitepaper: How Patient Journey Marketing™ delivers more value to your customers and your bottom line

Play Podcast

Download Related White Paper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Improving Clinical Operations at AstraZeneca

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 18 Jul 2008 16:39:00 -0500

Date:6/27/2008
Length: 00:16:09
Size: 7.39MB
Thought Leader: Karen Gotting-Smith, Ph.D. VP, Business Performance and Continuous Improvement, AstraZeneca Pharmaceuticals

Taren Grom, CoFounder and Editor-in-Chief of PharmaVOICE talks with Dr. Gotting-Smith about current market factors driving change in clinical operations, outsourcing considerations, new technologies and advances in data management.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

A Dual-Degree MSPharm/MBA Online Program for Life-Sciences Professionals

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 18 Jul 2008 16:37:00 -0500

Date:6/16/2008
Length: 00:09:10
Size: 4.2MB
Thought Leader: David B. Brushwood, R.Ph., J.D., Professor of Pharmaceutical Outcomes and Policy, University of Florida

In this episode, Professor Brushwood provides an overview of a new online dual-degree program: a Master of Science in Pharmacy degree from the University of Florida and a Master of Business Administration from Stetson University. He discusses the benefits of the dynamic dual-degree, the program structure, the advantages of an online program, and admission requirements.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Stiefel’s Dedication to Corporate Philanthropy

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 18 Jul 2008 16:36:00 -0500

Date: 6/19/2008
Length: 00:10:59
Size: 5.09MB
Thought Leader: Lyra Myers, Senior Global Category Manager, Stiefel Laboratories

In this episode, Taren Grom, Editor of PharmaVOICE, speaks with Lyra Myers about Stiefel’s many activities in corporate philanthropy, as well as her personal commitment to worthy causes.
Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Amgen’s Commitment to Philanthropy

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 18 Jul 2008 16:35:00 -0500

Date:6/13/2008
Length: 00:08:46
Size: 4.01MB
Thought Leader: Eduardo Cetlin, Senior Manager of Corporate Contributions, Amgen

In this special episode, Taren Grom, Editor of PharmaVOICE, speaks with Eduardo Cetlin, who discusses the Amgen Foundation, how Amgen encourages employees to become involved in volunteerism, his favorite service endeavors, and the overall goal of Amgen's philanthropic efforts.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

A Personal Dedication to Volunteerism and Mentoring

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 18 Jul 2008 16:32:00 -0500

Date:6/13/2008
Length: 00:12:44
Size: 5.82MB
Thought Leader: Sherrie Pietranico, Ph.D., Research Leader, Roche

In this special episode, Taren Grom, Editor of PharmaVOICE, speaks with Dr. Pietranico about her volunteer activities educating elementary school children about science, and how the Roche internship program helped one student become a successful scientist in the pharmaceutical industry.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Making Pharmacovigilance Work: Key steps for implementing a proactive, business-critical safety model

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 18 Jul 2008 16:30:00 -0500

Date: 6/5/2008
Length: 00:06:39
Size: 3.04MB

Thought Leader: Uwe Maennl, M.D., Ph.D., VP and Worldwide Head of Pharmacovigilance, PAREXEL International and Gadi Saarony, Corporate VP and Worldwide Head, PAREXEL Consulting

In this episode, Dr. Maennl and Mr. Saarony discuss a new safety model for pharmacovigilance, including risk management, key stakeholders, and performance benchmarks to this new approach.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Redefining the CRO

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 3 Jun 2008 12:31:00 -0500

Date: 5/7/2008
Length: 00:13:29
Size: 6.17MB

Thought Leader: Bob Burford Ph.D., Managing Director, Aptuit Consulting

In this episode, we discuss the relationship between drug developers and CROs, including current market conditions, the changing needs of drug developers, how to choose an outsourcing provider, expectations of a CRO, and the future of this important relationship.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Counter-Launch Planning: Pre-empting and Protecting Against Competitive Product Launches

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 3 Jun 2008 12:29:00 -0500

Date: 5/6/2008
Length: 00:10:33
Size: 4.83MB

Thought Leader: Stan Bernard, M.D., MBA, President, Bernard Associates LLC

Dr. Bernard discusses the underutilized concept of Counter Launch Planning (CLP) for protecting an established brand, including what it is, why it's important, who participates in the process, how it differs from traditional marketing and war games, and finally, important execution considerations.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Precommercial Marketing and Planning: Securing Future Success through Meaningful Differentiation

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 3 Jun 2008 12:26:00 -0500

Date: 4/30/2008
Length: 00:10:58
Size: 5.02MB

Thought Leader: Laurie Lucas, Founder and Principal, L3 Healthcare Marketing LLC

This Podcast covers several issues related to starting the marketing sequence earlier in the development cycle, including the differences between precommercial marketing and traditional product marketing, who the stakeholders are, what the necessary activities are, and some best practices for these activities.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Making it Stick – How Can Patient Education Really Make a Difference

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 8 May 2008 07:20:00 -0500

Date: 4/30/2008
Length: 00:11:50
Size: 5.42MB

Thought Leaders: Dr. Stanley Wulf, Chief Medical Officer, InfoMedics, and Ray Bullman, Executive VP of NCPIE (National Council on Patient Information and Education)

This Podcast covers several key issues related to patient education and patient adherence, including who the key players are, what they can do to improve patient education, and what the pharmaceutical companies can do to raise the effectiveness of patient education.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Late-Phase Research Success: Leveraging Secondary Data

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 8 May 2008 07:19:00 -0500

Date: 4/28/2008
Length: 00:16:02
Size: 7.34MB

Thought Leader: Cyndi Verst, Pharm.D., M.S., Senior VP, Global Late Phase, i3 InnovusThis Podcast covers the benefits of blending scientific and commercial objectives in late-phase research — saving time and money — the use of specialized data assets, the challenges of leveraging secondary data assets, and what is in store for late-phase research in the near future.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Enhancing Global Market Access Strategies with Named Patient Programs

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 8 May 2008 07:17:00 -0500

Date: 4/23/2008
Length: 00:12:14
Size: 5.60MB

Thought Leaders: John Lagus, VP of Business and Corporate Development, IDIS

This final installment in a three-part series covers how named patient programs can be used for market development, assist with regulatory challenges, address reimbursement issues, and develop key opinion leaders, and more.

Play Podcast

Free Whitepaper Download: "Enhancing Global Market Access Strategies with Named Patient Programs"
Download RelatedWhite Paper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The Future of Pharma CRM

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 8 May 2008 07:15:00 -0500

Date: 4/22/2008
Length: 00:15:43
Size: 7.19MB

Thought Leader: Matt Wallach, VP Sales and Marketing, Verticals onDemand, Inc.

This podcast covers the changing pharmaceutical sales and marketing model and the tools and solutions that are needed to shape the future of salesforces.

Play Podcast

Free Whitepaper Download: "Getting SaaSy In Pharma: How SaaS CRM Technology Today's Beleaguered Pharmaceutical Companies."
Download Related White Paper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Silo Busting – New Approaches to Brand Development

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 8 May 2008 07:13:00 -0500

Date: 4/2/2008
Length: 00:09:13
Size: 4.21MB

Event Representative: Camille DeSantis, BS, MT (ASCP), Copresident & Managing Partner, Brand Strategy & Client Services, Guard Dog Brand Development LLC

This Podcast covers how brand development agencies and life-sciences companies can partner to achieve optimal results, including breaking down the silos between disciplines. We also cover market research and brand identity ROI, and how to handle soft measurables. And, finally, Ms. DeSantis provides three best practices that can be employed to improve brand value through communications.

Play Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Training Seminar: Medical Education for Pharmaceutical Professionals: Information, May 6, 2008

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 1 Apr 2008 08:44:00 -0500

Date: 3/20/2008
Length: 00:06:37
Size: 3.03MB

Event Representative: Dr. Paul M. Krueger, Associate Dean for Academic Affairs, at the UMDNJ School of Osteopathic Medicine in New Jersey

Dr. Krueger provides an overview of an upcoming, day-long seminar focused on the diagnosis and treatment of medical disorders: Fundamentals of Clinical Practice. This is the first in a series of instructional forums called Medical Education for Pharmaceutical Professionals, also known as MEPP. The first seminar will be held May 6, 2008, in New Jersey.

For seminar information and registration, click here.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The Unique Challenges and Opportunities in Emerging Markets: Seizing Potential in the New High-Growth Countries

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 3 Mar 2008 08:53:00 -0600

Date: 2/26/2008
Length: 00:16:29
Size: 7.55MB

Thought Leader: Stephen Potts, Regional Director for Healthcare – Asia Pacific, the Middle East and Africa, TNS Healthcare

Opportunities in emerging markets are numerous and challenging. This episode provides vital information on maximizing opportunities in the BRIC markets as well as the N-11 countries.

Play Full Podcast

Download Related Presentation

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Regulatory Concerns in Named Patient Programs

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 27 Feb 2008 15:28:00 -0600

Date: 2/19/2008
Length: 00:15:01
Size: 6.87MB

Thought Leader: Maria Kempshall, Head of Regulatory Affairs and Quality Assurance, IDIS

This is the second of three IDIS sponsored Podcasts covering named patient programs. In this episode, Ms. Kempshall gives a brief overview on the topic and then provides a detailed discussion on key regulatory issues, factors impacting pharmacovigilance, and finally, how to communicate the availability of a named patient program.

Play Full Podcast

Download Related Article

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Navigating the Formulary Market

dlimbach@pharmavoice.com (Daniel Limbach) — Wed, 13 Feb 2008 08:30:00 -0600

Date: 2/1/2008
Length: 00:14:26
Size: 6.60MB

Thought Leader: Jeff Thomas, President, inVentiv Strategy & Analytics

In this episode, Mr. Thomas discusses ways to develop effective formulary plans for new drugs and existing drugs with new indications, how to identify formulary opportunities, ways to use competitive intelligence in the plan development process, how brand managers can avoid common mistakes, and the best ways to communicate a plan to formulary decision makers.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Named Patient Programs: An Overview

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 5 Feb 2008 09:19:00 -0600

Date: 2/5/2008
Length: 00:18:17
Size: 8.37MB

Thought Leader: Natalie Douglas, CEO, IDIS

In this episode, Natalie Douglas provides an introduction to named patient programs, describes the factors that motivate pharmaceutical and biotech companies to implement these programs, and highlights the benefits to the patient as well as the sponsoring company.

Play Full Podcast

Download Related White Paper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

MSLs: An Evolving Specialty

dlimbach@pharmavoice.com (Daniel Limbach) — Tue, 5 Feb 2008 09:08:00 -0600

Date: 1/24/2008
Length: 00:09:58
Size: 4.56MB

Thought Leader: Robin L. Winter-Sperry, M.D., President and CEO of Scientific Advantage LLC and MSL Advantage LLC

In this episode, Dr. Robin Winter-Sperry, President and CEO of Scientific Advantage LLC and MSL Advantage LLC, talks about the evolving role of the medical science liaison (MSL), return on education, how MSLs are improving patient outcomes, the growing trend of the inclusion of MSLs by emerging companies, and best practices for MSLs working in virtual teams.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Own It: Transforming Public Perception of Pharma through Better Sales & Marketing Practices

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 26 Nov 2007 14:00:00 -0600

Date: 11/14/2007
Length: 00:12:40
Size: 5.79MB

Thought Leaders: Michael Ball, Ph.D., VP, Marketing and Product Management, InfoMedics, and Paul LeVine, VP, Analytical Services, InfoMedics

In this episode, Dr. Ball and Mr. LeVine talk about three key areas of brand management: public perception, principal stakeholders, and technology in sales and marketing practices.

Play full podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Precommercial Marketing and Planning: Laying the Ground Work for Future Success

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 29 Oct 2007 08:38:00 -0500

Date: 10/23/2007
Length: 00:14:53
Size: 6.81MB

Thought Leader: Laurie Lucas, Founder and Principal, L3 Healthcare Marketing

Ms. Lucas provides details on how to develop an informed view of the market for your brand during the precommercialization phase. The discussion covers the risks for not doing so, the benefits of a prelaunch strategy, and the tactics for ultimate success.

Play Full Podcast

Download the whitepaper (Requires Acrobat PDF Reader)

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Competitive Simulations: The New, Improved War Games

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 10 Sep 2007 06:30:00 -0500

Date: 9/7/2007
Length: 00:12:57
Size: 5.93MB
Thought Leader: Stan Bernard, M.D., MBA, President, Bernard Associates LLC

Dr. Bernard highlights the differences between competitive simulations and traditional business war games and discusses how customized competitive simulation exercises can provide strategic advantages for pharmaceutical brands and brand teams.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

The Brave New Real World: A Changing Paradigm for Documenting Product Value and Safety Postapproval

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 30 Aug 2007 10:36:00 -0500

Date: 8/29/2007
Length: 00:15:30
Size: 6.96MB

Thought Leader: Jeff Trotter, Senior VP, Lifecycle Sciences Group, Icon Clinical Research

Jeff Trotter speaks about the need for real-world value and safety in postmarketing research, the current landscape, designing new studies, and how the industry can leverage opportunities in the postapproval environment.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

ePRO's Impact on Clinical Trials

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 30 Aug 2007 10:33:00 -0500

Date: 8/27/2007
Length: 00:12:14
Size: 5.60MB
Thought Leader: Jean Paty, Ph.D., Founder and Senior VP, Scientific, Quality and Regulatory Affairs, invivodata

Dr. Paty talks about a defining moment in clinical trial data, how ePRO will revolutionize clinical trials, improving the adoption of ePRO, and the future of clinical data technology.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Incorporating Electronic Health Records in the Trial Process

dlimbach@pharmavoice.com (Daniel Limbach) — Thu, 30 Aug 2007 10:29:00 -0500

Date: 8/27/2007
Length: 00:17:54
Size: 8.19MB

Thought Leader: James Rogers, CEO, Nextrials Inc.

Taren Grom, Cofounder and Editor of PharmaVOICE magazine, and James Rogers, CEO of Nextrials, discuss the benefits of incorporating electronic health records (EHR) into the clinical-trial process, what the challenges are, and how EHR can be used in other areas, such as patient recruitment.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Early Adopters Using SAFE Digital Signatures

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 17 Aug 2007 15:49:00 -0500

Date: 6/19/2007
Length: 00:6:49
Size: 3.12MB
Thought Leader: Mollie Shields-Uehling, President and CEO, SAFE Biopharma Association

Dan Limbach, Producer, PharmaVOICE Webcast Network, speaks with Mollie Shields-Uehling, who provides an overview of the SAFE digital signature technology, the benefits of electronic submissions, and which companies are adopting this model.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Trends in Patient Recruitment

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 17 Aug 2007 15:47:00 -0500

Date: 6/19/2007
Length: 00:5:50
Size: 2.67MB

Thought Leader: Bonnie Brescia, Cofounder, BBK Worldwide

Taren Grom, Cofounder and Editor of PharmaVOICE, speaks with Bonnie Brescia about the changing role of the pharmaceutical company in patient recruitment.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Managing Chargebacks to Boost the Bottom Line

dlimbach@pharmavoice.com (Daniel Limbach) — Fri, 17 Aug 2007 15:19:00 -0500

Date: 8/17/2007
Length: 00:19:23
Size: 8.87MB

Thought Leader: Al Godley, Director of Life-Science Solutions, Edge Dynamics

Al Godley explains the impact that chargebacks have on manufacturers' bottom lines, why chargebacks continue to be a source of silent revenue leakage, and best practices for chargeback management.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Improving Patient Compliance Using Ethnographic Research

dlimbach@pharmavoice.com (Daniel Limbach) — Mon, 13 Aug 2007 08:50:00 -0500

Date: 7/26/2007
Length: 00:15:21
Size: 7.02MB
Thought Leader: Stuart Paul, CEO, Communication Science Inc.

Stuart Paul outlines an innovative model that uses ethnographic research and evidence-based communications to achieve better health outcomes.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.